1. Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study.
- Author
-
Lomholt-Welch, Harriet, Morrow, Andrew, Sykes, Robert, Saleh, Merna, Zahra, Baryab, MacIntosh, Alasdair, Kamdar, Anna, Bagot, Catherine, Bayes, Hannah, Blyth, Kevin, Bulluck, Heerajnarain, Carrick, David, Church, Colin, Corcoran, David, Findlay, Iain, Gibson, Vivienne, Gillespie, Lynsey, Grieve, Douglas, Barrientos, Pauline, and Ho, Antonia
- Subjects
DISEASE progression ,COVID-19 ,FUNCTIONAL status ,POST-acute COVID-19 syndrome ,HEALTH status indicators ,MAGNETIC resonance imaging ,ATTITUDES toward illness ,HOSPITAL care ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,QUALITY of life ,RESEARCH funding ,MENTAL depression ,ANXIETY ,COMPUTED tomography ,MENTAL illness ,LONGITUDINAL method - Abstract
Background: The multisystem associations between baseline mental health status and coronavirus disease-19 (COVID)-19 illness trajectory are uncertain. Objectives: This article will investigate the associations between baseline mental health status and disease trajectory following COVID-19 hospitalization, which may have implications for practice and future research. Methods: The Chief Scientist Office Cardiovascular and Pulmonary Imaging in severe acute respiratory syndrome (SARS) COVID-19 study is a prospective, observational, multicenter, longitudinal, secondary care cohort study that assessed the time-course of multi-organ injury in posthospital survivors of COVID-19. Patients were assessed in-hospital, at 28–60 days after discharge and in the longer term using electronic health record linkage. Results: One hundred and fifty-two patients (mean ± standard deviation [SD] age 54.3 ± 11.8 years, 43% female, 40% most socio-economically deprived quintile, 33% history of mental health history) were enrolled and had mental health serially assessed using the Patient Health Questionnaire-4 (PHQ-4) questionnaire. Fifty-three (35%) had PHQ-4 score of 6–12 consistent with moderate-severe symptoms of anxiety or depression and this was associated with diagnostic criteria for myocarditis (P = 0.0498). Moderate-severe symptoms of anxiety or depression were positively associated with higher perception of illness, lower health-related quality of life (HRQoL), and poorer physical function. The mean (SD) duration of follow-up after hospital discharge was 428 (86) days (range, 290–627 days). PHQ-4 score was not associated with clinical outcomes at follow-up. Conclusions: In patients who have been hospitalized with COVID-19, moderate-severe symptoms of anxiety or depression were associated with myocarditis, worse HRQoL, higher perception of illness, and lower levels of physical function. Public Registration: ClinicalTrials.gov identifier is NCT04403607. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF